Brought to you by:
-
American Venous Forum, AVF 2023, chronic venous insufficiency, Venous disease, venous reflux, VenoValve
Bioprosthetic venous valve: ‘We want to know that this is really working’
A key investigator in efforts to tackle chronic venous insufficiency (CVI) with an bioprosthetic venous valve replacement talks about progress being made with surgical and endovascular versions of the device—and surgical community skepticism. Jorge Ulloa, MD, has not long since produced the latest data from a first-in-human (FIH) trial for emerging stainless-steel frame-based surgical implant,…
-
Venous stenting: ‘We need to evaluate use, appropriateness and clinical indication’
An analysis of venous stent usage trends in the United States from 2014 through 2021 showed a “significant increase” in stents per day placed over time, despite high-profile recalls of two dedicated venous stents from the market. Those were among the observations of Karem Harth, MD, associate professor of surgery and director of the Center…
-
VAM 2023: Early-bird registration opens
Meeting registration and hotel reservations opened March 15 for the Society for Vascular Surgery (SVS) 2023 Vascular Annual Meeting (VAM). This year’s premiere educational event for all vascular professionals will be June 14–17 at the National Resort and Convention Center in National Harbor, Maryland, just outside Washington, D.C. Early-bird registration pricing will be in effect…
-
AVF 2023: Results from first US trial of Sonovein delivered
The 2023 annual meeting of the American Venous Forum (AVF) heard the final results from the first U.S. trial of the emerging varicose vein treatment, Sonovein echotherapy, with data showing a 100% technical feasibility at three months—which was the principal study objective. Antonios Gasparis, MD, director of the Center for Vein Care at Stony Brook…
-
VESS 2023: pMAC score found to be ‘important predictor’ of CLTI revascularization outcomes
Having observed a strong relationship between calcification and subsequent limb loss, a research team led by investigators from the University of California San Francisco (UCSF) have conducted a single-center, retrospective follow-up extending an initial study evaluating pedal medial arterial calcification (pMAC) score and major amputation in patients with chronic limb-threatening ischemia (CLTI). Presented at the…
-
AVF 2023: FLASH registry suggests ‘favorable safety and effectiveness profile’ in high-risk PE patients
Among 61 high-risk pulmonary embolism (PE) patients followed through to the 30-day visit in the U.S. cohort of the FLASH registry, no mortalities were recorded, while at 48 hours post-treatment with the FlowTriever mechanical embolectomy system, likewise, there were no major adverse events (MAEs), nor serious adverse events (SAEs) reported. The outcomes emerged during a…
-
AVF 2023: Investigators report update on three-year first-in-human results for bioprosthetic venous valve
Researchers in Colombia behind the first-in-human study of a novel bioprosthetic venous valve designed to treat chronic venous insufficiency (CVI) reported three-year results among eight patients during the 2023 annual meeting of the American Venous Forum (Feb. 22–25) in San Antonio, Texas, providing attendees with updated data on improvements in venous reflux of 63%, revised…
-
VAM 2023 meeting set to take place as exclusively in-person event
A block party on opening day, session recordings available daily and—of course—the educational and scientific sessions for which the Society for Vascular Surgery’s Vascular Annual Meeting (VAM) is known: all this and much more will be part of VAM 2023. The premiere educational event of the vascular world will be June 14 to 17 at…
-
Educate, educate, and educate again: The continuing quest for appropriate venous care
Prominent venous disease experts discuss venous stenting, appropriate care, and the pursuit of refined data and better education in a space where part of the problem involves practitioners moving “freely from being able to do arterial intervention and suddenly assume they can do a venous intervention.” Education across the venous care delivery spectrum lies at…
-
VQI study leader highlights virtue of multispecialty gathering of best longitudinal data on PAD procedures
Daniel Bertges, MD, talks to Vascular Specialist about recent findings from his work investigating the IN.PACT Admiral drug-coated balloon (DCB). He related how they showed promising results in treating femoropopliteal in-stent restenosis in a Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry-based, postmarket surveillance study. Speaking at Vascular Interventional Advances (VIVA) 2022 in…